Q: I read that CMS changed the scope of work for the Beneficiary and Family Centered Care Quality Improvement Organizations (BFCC-QIO) Livanta and Kepro recently. What impact has that had on hospitals?
This week’s Medicare updates include two rules on price transparency, updates to medical review requirements for SNFs, annual updates to the therapy code list, and more!
Expanded price transparency requirements are set to become reality for hospitals effective January 1, 2021. On November 15, CMS released a final rule that pushed ahead with many of the requirements originally included in the 2020 OPPS proposed rule.
Q: When a diabetic patient has arteriosclerotic peripheral artery disease (PAD), should an additional ICD-10-CM code be assigned from subcategory I70.2- (atherosclerosis of native arteries of extremities) to describe the affected vessel and laterality?
